Cabozantinib

Cabozantinib

Cabozantinib (XL184) is a potent, orally active VEGFR2 and MET inhibitor (IC50 = 0.035 and 1.3 nM, respectively) with additional activity against KIT, RET, AXL, TIE2, and FLT3, exhibiting antiangiogenic and pro-apoptotic effects in tumors. Reagent grade, for research use only.

Molecular structure of the compound BP-43629
    • Unit
    • Price
    • Qty
    • 1 G
    • $120.00
    • 5 G
    • $320.00
    • 10 G
    • $540.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire